Associated Papers
TP53 germline pathogenic variants in modern humans were likely originated during recent human history.
Kou SH et al.
Nar Cancer, 2023
37304756 (PubMed )
Supplement: zcad025_supplemental_files.zip › Supplementary_Table_2.xlsx › BVs
Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene.
Doffe F et al.
Cell Death and Differentiation, 2021
33257846 (PubMed )
Supplement: 41418_2020_672_MOESM1_ESM.pdf
From uncertainty to pathogenicity: clinical and functional interrogation of a rare TP53 in-frame deletion.
Quinn EA et al.
Cold Spring Harbor Molecular Case Studies, 2019
30886117 (PubMed )
Supplement: supp_mcs.a003921_Supplemental_Table_1a.xlsx › S_Table1a._TP53_in_ClinVar
Variation analysis of PUM1 gene in Chinese women with primary ovarian insufficiency.
Luo W et al.
Journal of Assisted Reproduction and Genetics, 2018
TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma.
Andrade RC et al.
Familial Cancer, 2018
p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors.
Venneti S et al.
Journal of Neuropathology and Experimental Neurology, 2011
Select a paper to view details